American Journal of Obstetrics and Gynecology

Mechanism of neonatal hypoglycemia after late preterm steroids: are fetal metabolic effects responsible?.  227:347-349.e4. 2022

Impact of pushing timing on occult injury of levator ani: secondary analysis of a randomized trial.  226:718.e1-718.e10. 2022

Effect of vitamin D supplementation on urinary incontinence in older women: ancillary findings from a randomized trial.  226:535.e1-535.e12. 2022

Unified standard for fetal growth: the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies.  226:576-587.e2. 2022

Treatment and prevention of viral hepatitis in pregnancy.  226:335-346. 2022

Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis.  226:187-204.e15. 2022

Acute histologic chorioamnionitis independently and directly increases the risk for brain abnormalities seen on magnetic resonance imaging in very preterm infants 2022

Association between the urogenital microbiome and surgical treatment response in women undergoing midurethral sling operation for mixed urinary incontinence.  226:93.e1-93.e15. 2022

Racism and perinatal health inequities research: where we have been and where we should go 2022

Cost-effectiveness of behavioral and pelvic floor muscle therapy combined with midurethral sling surgery vs surgery alone among women with mixed urinary incontinence: results of the Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence randomized trial.  225:651.e1-651.e26. 2021

Prediction of vaginal birth after cesarean delivery in term gestations: a calculator without race and ethnicity.  225:664.e1-664.e7. 2021

Defining mechanisms of recurrence following apical prolapse repair based on imaging criteria.  225:506.e1-506.e28. 2021

Differences in obstetrical care and outcomes associated with the proportion of the obstetrician's shift completed.  225:430.e1-430.e11. 2021

Cervical length distribution and other sonographic ancillary findings of singleton nulliparous patients at midgestation.  225:181.e1-181.e11. 2021

Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial.  225:153.e1-153.e31. 2021

Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.  224:428-444.e8. 2021

Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia.  223:739.e1-739.e13. 2020

Cytomegalovirus infection during pregnancy: state of the science.  223:330-349. 2020

Chronic hypertension in pregnancy.  222:532-541. 2020

Impact of treatment for fecal incontinence on constipation symptoms.  222:590.e1-590.e8. 2020

Cervicovaginal fluid proteomic analysis to identify potential biomarkers for preterm birth.  222:493.e1-493.e13. 2020

Early gestational diabetes screening in obese women: a randomized controlled trial.  222:495.e1-495.e8. 2020

RE Letter to the Editor: Prehypertension is associated with multiple poor maternal and fetal outcomes, by Giovanni Sisti.  222:514. 2020

Health resource utilization of labor induction versus expectant management.  222:369.e1-369.e11. 2020

Association between adjuvant posterior repair and success of native tissue apical suspension.  222:161.e1-161.e8. 2020

Defining the relationship between vaginal and urinary microbiomes.  222:154.e1-154.e10. 2020

Intrauterine growth discordance across gestation and birthweight discordance in dichorionic twins.  222:174.e1-174.e10. 2020

Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth Studies.  221:635.e1-635.e16. 2019

Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.  221:513.e1-513.e15. 2019

Miscarriage among women in the United States Women's Interagency HIV Study, 1994–2017.  221:347.e1-347.e13. 2019

A contemporary amniotic fluid volume chart for the United States: The NICHD Fetal Growth Studies–Singletons.  221:67.e1-67.e12. 2019

Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis.  221:9-18.e8. 2019

Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis..  221:9-18.e8. 2019

Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.  220:265.e1-265.e11. 2019

Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo-controlled trial.  220:89.e1-89.e8. 2019

Fetal growth velocity: the NICHD fetal growth studies.  219:285.e1-285.e36. 2018

Neonatal outcomes of elective early-term births after demonstrated fetal lung maturity.  219:296.e1-296.e8. 2018

Reply.  219:121. 2018

Lessons learned from domestic and international human papillomavirus vaccination programs: a review.  218:467-473. 2018

SMFM Special Report: Putting the “M” back in MFM: Reducing racial and ethnic disparities in maternal morbidity and mortality: A call to action.  218:B9-B17. 2018

Defining failed induction of labor.  218:122.e1-122.e8. 2018

Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids.  218:130.e1-130.e13. 2018

Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.  218:111.e1-111.e9. 2018

A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.  217:678.e1-678.e9. 2017

The effect of omega-3 supplementation on pregnancy outcomes by smoking status.  217:476.e1-476.e6. 2017

Population-attributable fraction of tubal factor infertility associated with chlamydia.  217:336.e1-336.e16. 2017

Preemptive analgesia for postoperative hysterectomy pain control: systematic review and clinical practice guidelines.  217:303-313.e6. 2017

The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.  217:369.e1-369.e9. 2017

Maternal stress and neonatal anthropometry: the NICHD Fetal Growth Studies.  217:82.e1-82.e7. 2017

Preventing human papillomavirus–related cancers: we are all in this together.  216:576.e1-576.e5. 2017

Validity of self-reported history of Chlamydia trachomatis infection.  216:393.e1-393.e7. 2017

Infant outcomes among women with Zika virus infection during pregnancy: results of a large prenatal Zika screening program.  216:292.e1-292.e8. 2017

Transitioning from HPV 101 to HPV 202.  216:206-207. 2017

699: Disparities in postpartum glucose tolerance testing in women with gestational diabetes.  216:S409-S410. 2017

700: Placental abnormalities associated with isolated single umbilical artery.  216:S410-S410. 2017

Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence.  216:55.e1-55.e16. 2017

Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative women.  216:71.e1-71.e16. 2017

Dichorionic twin trajectories: the NICHD Fetal Growth Studies.  215:221.e1-221.e16. 2016

Preterm neonatal morbidity and mortality by gestational age: A contemporary cohort.  215:103.e1-103.e14. 2016

Revisiting the cost-effectiveness of universal cervical length screening: Importance of progesterone efficacy.  215:101.e1-101.e7. 2016

Prenatal screening for fetal aneuploidy: Time to examine where we are and where we are going.  214:673-675. 2016

Functional status in older women diagnosed with pelvic organ prolapse.  214:613.e1-613.e7. 2016

Cervical cancer screening: Evidence behind the guidelines.  214:438-443. 2016

Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth Presented in part as a poster presentation at the 35th Annual Society of Maternal Fetal Medicine Meeting, San Diego, CA, February 2-7, 2015..  214:376.e1-376.e8. 2016

Reply.  214:296-297. 2016

Stein and Leventhal: 80 years on.  214:247.e1-247.e11. 2016

The use of quality metrics in health care: Primum non nocere and the law of unintended consequences.  214:143-144. 2016

#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.  214:6-14. 2016

491: The efficacy of early amniotomy after ripening with Foley balloon catheter in nulliparous labor induction.  214:S268-S269. 2016

#37: Diagnosis and management of vasa previa.  213:615-619. 2015

Evaluating gestational weight gain recommendations in pregestational diabetes.  213:563.e1-563.e5. 2015

Racial/ethnic standards for fetal growth: The NICHD Fetal Growth Studies.  213:449.e1-449.e41. 2015

Serious maternal complications after early preterm delivery (24-33 weeks' gestation).  213:538.e1-538.e9. 2015

The female urinary microbiome in urgency urinary incontinence.  213:347.e1-347.e11. 2015

Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals.  213:398.e1-398.e11. 2015

Survey of American obstetricians regarding group B streptococcus: Opinions and practice patterns.  213:229.e1-229.e7. 2015

Does the presence of a condition-specific obstetric protocol lead to detectable improvements in pregnancy outcomes?.  213:86.e1-86.e6. 2015

Obesity and perioperative pulmonary complications in robotic gynecologic surgery.  213:33.e1-33.e7. 2015

Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis.  212:812.e1-812.e6. 2015

Reply.  212:690-691. 2015

The GoMo study: A randomized clinical trial assessing neonatal pain with Gomco vs Mogen clamp circumcision.  212:664.e1-664.e8. 2015

The GoMo study: a randomized clinical trial assessing neonatal pain with Gomco vs Mogen clamp circumcision.  212. 2015

The phenotype of spontaneous preterm birth: Application of a clinical phenotyping tool.  212:487.e1-487.e11. 2015

Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: A systematic review.  212:145-156. 2015

773: The association of isolated single umbilical artery with birthweight and preterm birth.  212:S375-S375. 2015

Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants.  212:94.e1-94.e7. 2015

Nonmedically indicated induction vs expectant treatment in term nulliparous women.  212:103.e1-103.e7. 2015

Review of multicenter studies by multiple institutional review boards: Characteristics and outcomes for perinatal studies implemented by a multicenter network.  212:110.e1-110.e6. 2015

The future of obstetrics/gynecology in 2020: A clearer vision. Transformational forces and thriving in the new system.  212:28-33.e1. 2015

Maternal serum serpin B7 is associated with early spontaneous preterm birth.  211:678.e1-678.e12. 2014

Mode of delivery in women with class III obesity: Planned cesarean compared with induction of labor.  211:700.e1-700.e9. 2014

The future of obstetrics/gynecology in 2020: A clearer vision: Finding true north and the forces of change.  211:617-622.e1. 2014

Effectiveness of blinding: Sham suprapubic incisions in a randomized trial of retropubic midurethral sling in women undergoing vaginal prolapse surgery.  211:554.e1-554.e7. 2014

Hyperglycemia impairs cytotrophoblast function via stress signaling.  211:541.e1-541.e8. 2014

Pelvic organ prolapse in a cohort of women treated for stress urinary incontinence.  211:550.e1-550.e5. 2014

The future of obstetrics/gynecology in 2020: A clearer vision. Why is change needed?.  211:470-474.e1. 2014

The utility of ultrasound surveillance of fluid and growth in obese women.  211:524.e1-524.e8. 2014

Thyroid screening in pregnancy.  211:351-353.e1. 2014

Findings of universal cystoscopy at incontinence surgery and their sequelae.  210:480.e1-480.e8. 2014

A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.  211:68.e1-68.e8. 2014

Can differences in obstetric outcomes be explained by differences in the care provided? the MFMU Network APEX study.  211:147.e1-147.e16. 2014

Inadequate weight gain in overweight and obese pregnant women: What is the effect on fetal growth?.  211:137.e1-137.e7. 2014

Is total thyroxine better than free thyroxine during pregnancy?.  211:132.e1-132.e6. 2014

Mycoplasma, bacterial vaginosis-associated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort.  210:226.e1-226.e7. 2014

Reply.  209:396. 2013

Transvaginal cervical cerclage: Evidence for perioperative management strategies.  209:181-192. 2013

Putting the "m" back in maternal-fetal medicine.  208:442-448. 2013

Erratum: Maternal antidepressant use and adverse outcomes: A cohort study of 228,876 pregnancies (American Journal of Obstetrics and Gynecology (2012) 207 49 (e1-9)).  208:326. 2013

Adherence to criteria for transvaginal ultrasound imaging and measurement of cervical length.  209:365.e1-365.e5. 2013

Effect of corticosteroid interval on markers of inflammation in spontaneous preterm birth.  209:379.e1-379.e6. 2013

Human papillomavirus: What every provider should know.  208:169-175. 2013

Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment.  209:244.e1-244.e9. 2013

Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.  209:51.e1-51.e6. 2013

Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals.  209:446.e1-446.e30. 2013

The pelvic floor complication scale: A new instrument for reconstructive pelvic surgery.  208:81.e1-81.e9. 2013

The role of the fallopian tube in the origin of ovarian cancer.  209:409-414. 2013

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.  207:390.e1-390.e8. 2012

Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus.  206:422.e1-422.e5. 2012

Gestational age at delivery and perinatal outcomes of twin gestations.  207:410.e1-410.e6. 2012

Maternal BMI, glucose tolerance, and adverse pregnancy outcomes.  207:62.e1-62.e7. 2012

Maternal antidepressant use and adverse outcomes: A cohort study of 228,876 pregnancies.  207:49.e1-49.e9. 2012

Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model.  207:475.e1-475.e14. 2012

Pharmacologic treatment for urgency-predominant urinary incontinence in women diagnosed using a simplified algorithm: A randomized trial.  206:444.e1-444.e11. 2012

The new American Journal of Obstetrics and Gynecology, 5 years later: Looking back and moving forward.  206:364-373. 2012

Timing of delivery and pregnancy outcomes among laboring nulliparous women.  206:239.e1-239.e8. 2012

Adhesion prevention in patients with multiple cesarean deliveries..  205:S19-S24. 2011

Bacterial vaginosis and STI risk: Allsworth et al.  205:158-159. 2011

Evaluation and management of adnexal mass in pregnancy.  205:97-102. 2011

Making the best match: Can we select the right residents for obstetrics and gynecology and for our own programs?.  204:369-370. 2011

Antithyroid antibodies and parity: Further evidence for microchimerism in autoimmune thyroid disease.  205:471.e1-471.e4. 2011

Discussion: 'Bacterial vaginosis and STI risk' by Allsworth et al.  205:e1. 2011

Does midtrimester Nugent score or high vaginal pH predict gestational age at delivery in women at risk for recurrent preterm birth?.  204:46.e1-46.e4. 2011

Maternal insulin resistance and preeclampsia.  204:327.e1-327.e6. 2011

Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth.  204:342.e1-342.e5. 2011

Racial and regional differences in age at menopause in the United States: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  205:353.e1-353.e8. 2011

Surgically managed stage i endometrial cancer in a low-volume center: Outcomes and complications in a military residency program.  205:356.e1-356.e5. 2011

Tinidazole vs metronidazole for the treatment of bacterial vaginosis.  204:211.e1-211.e6. 2011

17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.  202:351.e1-351.e6. 2010

Cervical funneling: Effect on gestational length and ultrasound-indicated cerclage in high-risk women.  203:259.e1-259.e5. 2010

Co-expression of GPR30 and ERβ and their association with disease progression in uterine carcinosarcoma.  203:242.e1-242.e5. 2010

Correlation between levator ani muscle injuries on magnetic resonance imaging and fecal incontinence, pelvic organ prolapse, and urinary incontinence in primiparous women.  202:488.e1-488.e6. 2010

Current diagnosis and treatment of interstitial pregnancy.  202:15-29. 2010

Discussion: 'Infant death among Ohio residents' by Donovan et al.  203:e8. 2010

Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women?.  203:393.e1-393.e5. 2010

Gestational age at previous preterm birth does not affect cerclage efficacy.  203:377.e1-377.e4. 2010

Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population.  202:297.e1-297.e8. 2010

Infant death among Ohio residents: Donovan et al.  203:86-87. 2010

Pelvic pain and surgeries in women before interstitial cystitis/painful bladder syndrome.  202:286.e1-286.e6. 2010

Reply.  201. 2009

Associated factors and the impact of fecal incontinence in women with urge urinary incontinence: from the Urinary Incontinence Treatment Network's Behavior Enhances Drug Reduction of Incontinence study.  200:424.e1-424.e8. 2009

Progesterone for preterm birth prevention: an evolving intervention.  200:219-224. 2009

A randomized, double-blinded, controlled trial comparing parenteral normal saline with and without dextrose on the course of labor in nulliparas.  200:379.e1-379.e6. 2009

Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: the CARDIA study.  201:177.e1-177.e9. 2009

Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.  200:188.e1-188.e7. 2009

Fecal incontinence in obese women with urinary incontinence: prevalence and role of dietary fiber intake.  200:566.e1-566.e6. 2009

Hot and blue. Lymphoscintigraphy might be useful in cervical cancer surgery.  201:223.e1-223.e2. 2009

Left upper quadrant laparoscopic placement: effects of insertion angle and body mass index on distance to posterior peritoneum by magnetic resonance imaging.  201:522.e1-522.e5. 2009

Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length.  201:375.e1-375.e8. 2009

Novel clomiphene protocol in polycystic ovarian syndrome: Hurst et al.  200:586-587. 2009

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.  200:457.e1-457.e5. 2009

To the point: reviews in medical education-the Objective Structured Clinical Examination.  200:25-34. 2009

Use of metformin in polycystic ovary syndrome.  199:596-609. 2008

To the point: medical education review of the role of simulators in surgical training.  199:338-343. 2008

Steering Committee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development's (NICHD) Maternal-Fetal Medicine Units Network.  199. 2008

A comprehensive review to establish priority learning objectives for medical students in the obstetrics and gynecology clerkship.  199:563.e1-563.e9. 2008

Chlamydial and gonococcal infections in women seeking pregnancy testing at family-planning clinics.  198:502.e1-502.e4. 2008

Diet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis.  198:287.e1-287.e6. 2008

Differential regulation of myometrial prostaglandin production by changes in length.  198:225.e1-225.e4. 2008

Discussion: 'Physician gender, specialty, and hysterectomy utilization' by Gretz et al.  199:e1. 2008

Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?.  198:30.e1-30.e7. 2008

Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age.  198:466.e1-466.e11. 2008

Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection.  199:303.e1-303.e3. 2008

Intraabdominal pressure changes associated with lifting: implications for postoperative activity restrictions.  198:306.e1-306.e5. 2008

Obesity and outcomes after sacrocolpopexy.  199:690.e1-690.e8. 2008

Outcomes of combination treatment of fecal incontinence in women.  199:699.e1-699.e7. 2008

Physician gender, specialty, and hysterectomy utilization: Gretz et al.  199:438-439. 2008

Rectovaginal examinations and human papillomavirus: can we decrease the risk of colorectal infection?.  198:260.e1-260.e2. 2008

The Alabama Preterm Birth Study: Umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants.  198:43.e1-43.e5. 2008

The increasing racial disparity in infant mortality rates: Composition and contributors to recent US trends.  198:51.e1-51.e9. 2008

To the point: medical education review of the RIME method for the evaluation of medical student clinical performance.  197:123-133. 2007

The outcome of infants with an Apgar score of zero at 10 minutes: past and future.  196:422-423. 2007

A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases.  196:517.e1-517.e6. 2007

ANGELS and University of Arkansas for Medical Sciences paradigm for distant obstetrical care delivery.  196:534.e1-534.e9. 2007

Bladder symptoms 1 year after abdominal sacrocolpopexy with and without Burch colposuspension in women without preoperative stress incontinence symptoms.  197:647.e1-647.e6. 2007

Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction.  197:367.e1-367.e6. 2007

Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters.  196:398.e1-398.e6. 2007

Effects of peritoneal closure and suture material on adhesion formation in a rabbit model.  197:644.e1-644.e5. 2007

Fetal loss and sickle cell trait: a valid association.  196. 2007

Impact of interconception antibiotics on the endometrial microbial flora.  196:226.e1-226.e6. 2007

Intrauterine device use in a high-risk population: experience from an urban university clinic.  197:193.e1-193.e7. 2007

Prevalence and risk factors of fecal incontinence in women undergoing stress incontinence surgery.  197:662.e1-662.e7. 2007

Race and ethnicity do not contribute to differences in preoperative urinary incontinence severity or symptom bother in women who undergo stress incontinence surgery.  197:92.e1-92.e6. 2007

Reply.  196. 2007

Risk factors for sonographic internal anal sphincter gaps 6-12 months after delivery complicated by anal sphincter tear.  197:310.e1-310.e5. 2007

Sexual function before and after sacrocolpopexy for pelvic organ prolapse.  197:629.e1-629.e6. 2007

Teaching and practicing of pelvic floor muscle exercises in primiparous women during pregnancy and the postpartum period.  197:107.e1-107.e5. 2007

The global network: a prospective study of stillbirths in developing countries.  197:247.e1-247.e5. 2007

The impact of fecal and urinary incontinence on quality of life 6 months after childbirth.  197:636.e1-636.e6. 2007

The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women.  197:488.e1-488.e5. 2007

Trends in neonatal morbidity and mortality for very low birthweight infants.  196:147.e1-147.e8. 2007

Association of asymptomatic bacterial vaginosis with endometrial microbial colonization and plasma cell endometritis in nonpregnant women.  195:1611-1616. 2006

Corticosteroids and HELLP.  195. 2006

Fetal growth risk curves: Defining levels of fetal growth restriction by neonatal death risk.  195:1571-1577. 2006

Placental transfer of rosiglitazone in the ex vivo human perfusion model.  195:1715-1719. 2006

Reply.  195. 2006

The Alabama Preterm Birth Study: Intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks.  195:1533-1537. 2006

The International Infections in Pregnancy (IIP) study: Variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women.  195:1198-1204. 2006

HPTN 024 study: Histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.  195:1065-1074. 2006

The Alabama Preterm Birth Study: Corticosteroids and neonatal outcomes in 23- to 32-week newborns with various markers of intrauterine infection.  195:1020-1024. 2006

The Alabama Preterm Birth Project: Placental histology in recurrent spontaneous and indicated preterm birth.  195:792-796. 2006

The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants.  195:803-808. 2006

Early mid-trimester serum relaxin, soluble CD163, and cervical length in women at high risk for preterm delivery.  195:208-214. 2006

Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometrium.  194:1384-1390. 2006

Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair.  194:1486-1491. 2006

Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.  194:1283-1289. 2006

Are women with recurrent spontaneous preterm births different from those without such history?.  194:1176-1184. 2006

To the Point: Reviews in medical education online computer assisted instruction materials.  194:1064-1069. 2006

Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.  194:774-781. 2006

Midpregnancy genitourinary tract infection with Chlamydia trachomatis: Association with subsequent preterm delivery in women with bacterial vaginosis and Trichomonas vaginalis.  194:493-500. 2006

Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: Resource use in the Medicine or Surgery (Ms) trial.  194:332-338. 2006

The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort.  194:381-386. 2006

A randomized trial of coached versus uncoached maternal pushing during the second stage of labor.  194:10-13. 2006

Interconceptional antibiotics to prevent spontaneous preterm birth: A randomized clinical trial.  194:617-623. 2006

Environmental contaminants and maternal thyroid function.  193:1889-1890. 2005

Factors associated with incontinence frequency in a surgical cohort of stress incontinent women.  193:2088-2093. 2005

Regret, satisfaction, and symptom improvement: Analysis of the impact of partial colpocleisis for the management of severe pelvic organ prolapse.  193:2067-2070. 2005

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial.  193:1630-1639. 2005

Reply.  193:1883-1883. 2005

The essential elements of undergraduate medical education in obstetrics and gynecology: A comparison of the Association of Professors of Gynecology and Obstetrics Medical Student Educational Objectives and the National Board of Medical Examiners Subject Examination.  193:1773-1779. 2005

Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy.  193:1478-1485. 2005

Do factors that are important during obstetrics and gynecology residency program selection differ by applicant gender?.  193:1540-1543. 2005

Endometrial microbial colonization and plasma cell endometritis after spontaneous or indicated preterm versus term delivery.  193:739-745. 2005

High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: A randomized trial.  193:1065-1070. 2005

The Maternal-Fetal Medicine Unit cesarean registry: Trial of labor with a twin gestation.  193:135-140. 2005

Pathologic uterine torsion associated with placental abruption, maternal shock, and intrauterine fetal demise.  192:2082-2083. 2005

A randomized trial of the effects of coached vs uncoached maternal pushing during the second stage of labor on postpartum pelvic floor structure and function.  192:1692-1696. 2005

Anal incontinence in women presenting for gynecologic care: Prevalence, risk factors, and impact upon quality of life.  192:1637-1642. 2005

Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes.  192:1162-1166. 2005

Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation?.  192:470-477. 2005

Obstetric antecedents for postpartum pelvic floor dysfunction.  192:1655-1662. 2005

To the point: Medical education reviews - Dealing with student difficulties in the clinical setting.  193:1915-1922. 2005

To the point: Medical education reviews evaluation in context: Assessing learners, teachers, and training programs.  192:34-37. 2005

WHI response to Ostrzenski and Ostrzenska.  193:1605-1606. 2005

The prevalence of androgen excess among patients with minimal unwanted hair growth.  191:1914-1920. 2004

To the point: Reviews in medical education teaching techniques.  191:408-411. 2004

Can shortened midtrimester cervical length predict very early spontaneous preterm birth?.  191:298-303. 2004

Number and gestational age of prior preterm births does not modify the predictive value of a short cervix.  191:241-246. 2004

Prophylactic progesterone to prevent preterm birth [3].  190:1799-1800. 2004

Reply.  190:1174-1174. 2004

An evaluation of trends in obstetrics and gynecology clerkships in the United States and Canada.  191:354-358. 2004

An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.  190:721-729. 2004

Assessing the impact of a comprehensive sexually transmitted disease curriculum on learning outcomes.  191:1822-1827. 2004

Cervicovaginal cytokines, vaginal infection, and preterm birth.  190:1179. 2004

Is early-pregnancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus?.  190:775-778. 2004

Laparoscopic supracervical hysterectomy.  191:1875-1884. 2004

Magnesium sulfate induces translocation of protein kinase C isoenzymes alpha and delta in myometrial cells from pregnant women.  190:522-527. 2004

Optical detection of high-grade cervical intraepithelial neoplasia in vivo: Results of a 604-patient study.  190:1249-1257. 2004

Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy.  190:737-744. 2004

Reproductive health history of lesbians: Implications for care.  190:1298-1304. 2004

Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment.  190:363-370. 2004

Clinical trial of chlorhexidine vaginal irrigation to prevent peripartal infection in nulliparous women.  189:166-170. 2003

Erratum: Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. (American Journal of Obstetrics and Gynecology (2002) 186 (422-426)).  189:244. 2003

Medroxyprogesterone acetate treatment of abnormal uterine bleeding: Factors predicting satisfaction.  189:37-42. 2003

Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on epidemiologic issues in urinary incontinence in women.  188. 2003

A cost-effectiveness analysis of management strategies for cervical intraepithelial neoplasia grades 2 and 3.  188:1186-1188. 2003

Differing symptoms of abused versus nonabused women in obstetric-gynecology settings.  188:707-713. 2003

Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women.  188:831-835. 2003

Maternal and transplacental pharmacokinetics of azithromycin.  188:714-718. 2003

Vaginal sonography and cervical incompetence.  188:586-596. 2003

Burden of stress urinary incontinence for community-dwelling women.  189:1275-1282. 2003

Cadaveric fascia lata sling for stress urinary incontinence: A prospective quality-of-life analysis.  189:1590-1595. 2003

It's time to challenge surgical dogma with evidence-based data..  189:423-427. 2003

Anesthesia for childbirth: Controversy and change.  186. 2002

Adolescents' ambivalence about becoming pregnant predicts infrequent contraceptive use: A prospective analysis of nonpregnant African American females.  186:251-252. 2002

Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.  186:66-71. 2002

Magnesium sulfate inhibits the oxytocin-induced production of inositol 1,4,5-trisphosphate in cultured human myometrial cells.  187:419-424. 2002

Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas.  186:422-426. 2002

Risk factors associated with anal sphincter tear: A comparison of primiparous patients, vaginal births after cesarean deliveries, and patients with previous vaginal delivery.  187:1194-1198. 2002

Severe preeclampsia at <25 weeks of gestation: Maternal and neonatal outcomes.  186:790-795. 2002

The Preterm Prediction Study: Elevated cervical ferritin levels at 22 to 24 weeks of gestation are associated with spontaneous preterm delivery in asymptomatic women.  186:458-463. 2002

Computed tomography and locating ureters in relation to the uterine cervix [2] (multiple letters).  185:1009-1010. 2001

The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..  184:483-488. 2001

Can prenatal ultrasound findings predict ambulatory status in fetuses with open spina bifida?.  185:1016-1020. 2001

Cesarean delivery rate among women with severe hypertensive disease - Possible reduction with epidural anesthesia? [1] (multiple letters).  184:514. 2001

Effect of carbon dioxide on human ovarian carcinoma cell growth.  185:1314-1317. 2001

Effects of pubovaginal sling procedure on patients with urethral hypermobility and intrinsic sphincteric deficiency: Would they do it again?.  184:14-19. 2001

Lack of utility of amniotic fluid index in predicting perinatal morbidity and mortality [4] (multiple letters).  184:778-779. 2001

Laminaria versus extra-amniotic saline solution infusion for cervical ripening in second-trimester labor inductions.  184:1145-1148. 2001

Location of the ureters in relation to the uterine cervix by computed tomography.  184:336-339. 2001

Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.  185:163-165. 2001

Nutrient intake and hypertensive disorders of pregnancy: Evidence from a large prospective cohort.  184:643-651. 2001

Outcomes among term infants when two-hour postnatal pH is compared with pH at delivery.  184:447-450. 2001

Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome.  185:1381-1387. 2001

The effect of the increasing prevalence of maternal obesity on perinatal morbidity.  185:845-849. 2001

The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.  184:1204-1210. 2001

The preterm prediction study: Association between cervical interleukin 6 concentration and spontaneous preterm birth.  184:483-488. 2001

The preterm prediction study: cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..  182:631-635. 2000

The preterm prediction study: granulocyte colony-stimulating factor and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network..  182:625-630. 2000

21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study.  183:1468-1474. 2000

Asymptomatic bacterial vaginosis: Response to therapy.  183:1434-1439. 2000

Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy.  183:1100-1102. 2000

Cost of neonatal care according to gestational age at birth and survival status.  182:170-175. 2000

Epidural anesthesia in severe preeclampsia [3] (multiple letters).  183:258. 2000

Erratum: Mid-trimester vaginal biological markers of infection predictive of lower genital tract fetal fibronectin (FFN) (American Journal of Obstetrics and Gynecology (2000) 182 (1-2)).  182:751. 2000

Expression of protein kinase C isozymes in nonpregnant and pregnant human myometrium.  183:1525-1531. 2000

Genital human papillomavirus infection in women who have sex with women: A review.  183:770-774. 2000

Hidden costs of infertility treatment in employee health benefits plans.  182:891-895. 2000

Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model.  182:553-559. 2000

Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks' gestation.  182:909-912. 2000

Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies.  183:1520-1524. 2000

Puerperal infection after cesarean delivery: Evaluation of a standardized protocol.  182:1147-1151. 2000

Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus.  182:364-369. 2000

Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.  183:805-809. 2000

The Preterm Prediction Study: Cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth.  182:631-635. 2000

The Preterm Prediction Study: Granulocyte colony-stimulating factor and spontaneous preterm birth.  182:625-630. 2000

The preterm prediction study: Association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth.  183:662-668. 2000

The preterm prediction study: Quantitative fetal fibronectin values and the prediction of spontaneous preterm birth.  183:1480-1483. 2000

What is the meaning of authorship? [1] (multiple letters).  183:775-776. 2000

Benefits of maternal corticosteroid therapy in infants weighing <1000 grams at birth after preterm rupture of the amnion.  180:677-682. 1999

Indicated versus spontaneous preterm delivery: An evaluation of neonatal morbidity among infants weighing ≤1000 grams at birth.  180:683-689. 1999

Obstetric determinants of neonatal survival: Antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants.  180:665-669. 1999

Prevalence of 3β-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess.  181:596-600. 1999

Prophylactic cesarean delivery for fetal macrosomia diagnosed by means of ultrasonography - A Faustian bargain?.  181:332-338. 1999

Prospective evaluation of free β-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.  181:887-892. 1999

Terbutaline [1] (multiple letters).  180:1593-1595. 1999

The Preterm Prediction Study: Failure of midtrimester cervical sialidase level elevation to predict subsequent spontaneous preterm birth.  180:1151-1154. 1999

The association of interleukin 6 with clinical and laboratory parameters of acute pelvic inflammatory disease.  181:940-944. 1999

Transperineal versus endovaginal ultrasonographic examination of the cervix in the midtrimester: A blinded comparison.  181:780-783. 1999

Cocaine augments contractility of the pregnant human uterus by both adrenergic and nonadrenergic mechanisms.  178:1077-1081. 1998

Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery.  178:546-550. 1998

Maternal serum α-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.  179:966-970. 1998

Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.  179:846-851. 1998

Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model.  179:758-761. 1998

Routine maternal platelet count: An assessment of a technologically driven screening practice.  179:573-576. 1998

Use of antibiotics to prevent preterm birth [2] (multiple letters).  178:624-625. 1998

Chlorhexidine vaginal irrigation for the prevention of peripartal infection: A placebo-controlled randomized clinical trial.  176:617-622. 1997

Electronic fetal heart rate monitoring: Research guidelines for interpretation.  177:1385-1390. 1997

Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies.  177:992-996. 1997

Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial.  177:13-18. 1997

Management options in women with preterm uterine contractions: A randomized clinical trial.  177:814-818. 1997

Maternal serum human chorionic gonadotropin level at 15 weeks.  176:258. 1997

Maternal serum human chorionic gonadotropin level at 15 weeks..  176:258. 1997

Obstetric determinants of neonatal survival: Influence of willingness to perform cesarean delivery on survival of extremely low-birth-weight infants.  176:960-966. 1997

Randomized trial of single-dose versus multiple-dose cefotetan for the postpartum treatment of intrapartum chorioamnionitis.  177:831-834. 1997

The differential expression of the HER-2/neu oncogene among high-risk human papillomavirus-infected glandular lesions of the uterine cervix.  177:133-138. 1997

The preterm prediction study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery.  177:8-12. 1997

The role of irrigation in the development of hypothermia during laparoscopic surgery.  176:598-602. 1997

α-fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.  177:987-991. 1997

Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group..  174:1618-1621. 1996

Bacterial colonization of the vagina during pregnancy in four ethnic groups.  174:1618-1621. 1996

Cocaine and β-adrenergic receptor function in pregnant myometrium.  175:1651-1653. 1996

Complications of midtrimester pregnancy termination: The effect of prior cesarean delivery.  175:889-892. 1996

Dynamics of the fetal adrenal, cholesterol, and apolipoprotein B responses to antenatal betamethasone therapy.  174:562-565. 1996

Effect of parity correction on Down syndrome detection by the multiple- marker screening test.  175:1004-1007. 1996

Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss.  175:830-833. 1996

On the use of surrogate end points for the calculation of the false- positive rate of antenatal testing [10].  175:756-757. 1996

Plasma ferritin and pregnancy outcome.  175:1356-1359. 1996

Pregnancy outcome and intelligence at age five years.  175:1511-1515. 1996

The feasibility of a randomized clinical perinatal trial: Maternal magnesium sulfate for the prevention of cerebral palsy.  175:701-705. 1996

The preterm prediction study: Maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation.  175:1286-1292. 1996

Cervical examination and tocodynamometry at 28 weeks' gestation: prediction of spontaneous preterm birth..  172:666-671. 1995

A comparison of the relative risk of vessel injury with conical versus pyramidal laparoscopic trocars in a rabbit model.  173:1731-1733. 1995

Amniotic fluid interleukin-6: Correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery.  173:606-612. 1995

Cervical examination and tocodynamometry at 28 weeks' gestation: Prediction of spontaneous preterm birth.  172:666-671. 1995

Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1–24) stimulation in hyperandrogenic women.  172:1251-1256. 1995

Comparion of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women ≥35 years old.  173:1287-1292. 1995

Determinants of the optimal time in gestation to initiate antenatal fetal testing: A decision-analytic approach.  173:1357-1363. 1995

Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension?.  173:1219-1222. 1995

Effects of sacrocolposuspension on the lower urinary tract.  173:1684-1689. 1995

Gestational diabetes survey.  172:615-620. 1995

Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia.  173:687-694. 1995

Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants.  173:299-305. 1995

Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.  173:578-584. 1995

Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation.  172:914-918. 1995

Practice variation in the use of corticosteroids: A comparison of eight data sets.  173:296-298. 1995

Risk factors for the development of preterm premature rupture of the membranes after arrest of preterm labor.  173:1310-1315. 1995

The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels.  173:1292-1296. 1995

The influence of maternal weight on human chorionic gonadotropin in the multiple-marker screening test for fetal Down syndrome.  173:1297-1300. 1995

The preterm prediction study: Significance of vaginal infections.  173:1231-1235. 1995

Third stage of labor: Analysis of duration and clinical practice.  172:1279-1284. 1995

Vascular anatomy of the anterior abdominal wall in gynecology and obstetrics [5].  172:1944-1945. 1995

The effect of corticosteroid therapy in the very premature infant. March of Dimes Multicenter Study Group..  170:869-873. 1994

Acid-base status at birth and subsequent neurosensory impairment in surviving 500 to 1000 gm infants.  170:48-53. 1994

Comparison of perceived and actual rates of survival and freedom from handicap in premature infants.  171:432-439. 1994

Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.  171:1038-1041. 1994

Oral Concurrent Session A Maternal Fetal Physiology.  170:268-270. 1994

Prediction of preterm birth in nulliparous patients.  171:1111-1115. 1994

The effect of corticosteroid therapy in the very premature infant.  170:869-873. 1994

The location of abdominal wall blood vessels in relationship to abdominal landmarks apparent at laparoscopy.  171:642-646. 1994

The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome.  171:1041-1046. 1994

Urinary complaints after modified Burch urethropexy: An analysis.  171:1460-1464. 1994

3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism.  168:889-895. 1993

A multicenter study of preterm birth weight and gestational age-specific neonatal mortality..  168:78-84. 1993

A multicenter study of preterm birth weight and gestational age—specific neonatal mortality.  168:78-84. 1993

Are pill counts valid measures of compliance in clinical obstetric trials?.  169:1181-1182. 1993

Association of low maternal serum α-fetoprotein levels and intrauterine growth retardation [5].  169:435. 1993

Cocaine selectively inhibits β-adrenergic receptor binding in pregnant human myometrium.  169:644-649. 1993

Effects of intrapartum stress on fetal adrenal function.  169:1407-1411. 1993

Low-dose aspirin therapy to prevent preeclampsia.  168:1083-1093. 1993

Maternal risk factors and their influence on fetal anthropometric measurements.  168:1197-1205. 1993

Midpregnancy serum thromboxane B2 determinations do not predict subsequent adverse pregnancy outcomes.  169:105-106. 1993

Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture.  169:976-981. 1993

Reply.  169:435. 1993

The effect of low-dose aspirin on fetal urine output and amniotic fluid volume.  169:885-888. 1993

The effect of low-dose aspirin on umbilical artery Doppler measurements.  169:907-911. 1993

Trial of labor after a one- or two-layer closure of a low transverse uterine incision.  168:545-546. 1993

Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group..  167:873-879. 1992

Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardation.  167:596-601. 1992

Hemorrhagic endovasculitis of the placenta and fetomaternal hemorrhage: A relationship?.  167:860. 1992

Midtrimester pregnancy termination: A randomized trial of prostaglandin E2 versus concentrated oxytocin.  167:1112-1116. 1992

Neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis.  167:873-879. 1992

Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial.  166:803-809. 1992

Transverse uterine incision closure: One versus two layers.  167:1108-1111. 1992

A case report of giant cell arteritis of the uterus and adnexa.  164:540-542. 1991

Cocaine directly augments the α-adrenergic contractile response of the pregnant rabbit uterus.  164:182-187. 1991

Drug abuse screening of childbearing-age women in Alabama public health clinics.  165:924-927. 1991

Neonatal complications at term as related to the degree of umbilical artery acidemia.  164:637-641. 1991

Oligohydramnios: Antepartum fetal urine production and intrapartum fetal distress.  165:1077-1080. 1991

Reply.  164:236. 1991

Was there really a difference with amnioinfusion? (Reply).  164:236. 1991

A comparison between umbilical artery velocimetry and standard antepartum surveillance in hospitalized high-risk patients.  162:710-714. 1990

A prospective randomized study of saline solution amnioinfusion.  162:1146-1149. 1990

Evaluation of a risk scoring system as a predictor of preterm birth in an indigent population.  163:873-879. 1990

Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population.  162:213-218. 1990

Intrauterine growth retardation is not the same as small for gestational age (I: Reply).  162:1643. 1990

Is indicated or spontaneous preterm delivery more advantageous for the fetus?.  163:868-872. 1990

Magnesium tocolysis: Serum levels versus success.  162:1177-1180. 1990

Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasia.  162:633-638. 1990

Reply.  162:1643. 1990

Retropubic long-needle suspension procedures for stress urinary incontinence.  163:551-557. 1990

Smoking, maternal age, fetal growth, and gestational age at delivery.  162:53-58. 1990

Study of preterm birth draws different interpretation.  162:1626-1627. 1990

The relationship between maternal serum and amniotic fluid α-fetoprotein in women undergoing early amniocentesis.  163:903-906. 1990

Transplacental transfer of zidovudine in the near-term pregnant baboon.  163:728-732. 1990

Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm delivery.  162:748-754. 1990

Compensatory ovarian hypertrophy occurs by a mechanism distinct from compensatory growth in the regenerating liver..  161:1653-1657. 1989

A comparison of perinatal outcome in patients undergoing contraction stress testing performed by nipple stimulation versus spontaneously occurring contractions.  160:1081-1085. 1989

Comparison of predelivery versus postdelivery Kleihauer-Betke stains in cases of fetal death.  161:663-666. 1989

Compensatory ovarian hypertrophy occurs by a mechanism distinct from compensatory growth in the regenerating liver.  161:1653-1657. 1989

Endocrine maturation and lung function in premature neonates of women with diabetes.  160:657-662. 1989

Identification of a deoxyribonucleic acid allelic variant for β1-4 galactosyltransferase expression associated with male sperm binding/penetration infertility.  160:1160-1165. 1989

Indomethacin-induced oligohydramnios.  160:1196-1197. 1989

Intrauterine growth retardation: Standards for diagnosis.  161:271-277. 1989

Polyarteritis nodosa in pregnancy: A case report and brief literature review.  160:606-607. 1989

Prematurity, postdates, and growth retardation: The influence of use of ultrasonography on reported gestational age.  160:462-470. 1989

Prolactin levels in umbilical cord blood of human infants: Relation to gestational age, maternal complications, and neonatal lung function.  161:795-802. 1989

The effects of syphilis on endocrine function of the fetoplacental unit..  159:1327-1331. 1988

Acute myometritis and chorioamnionitis during cesarean section of asymptomatic women.  159:1137-1139. 1988

Association of HLA-linked factor B with gestational diabetes mellitus in black women.  159:805-806. 1988

Effects of ritodrine hydrochloride on arteriovenous blood gas and shunt in healthy pregnant yellow baboons.  158:658-663. 1988

Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil.  158:1169-1170. 1988

Adenosquamous carcinoma of the fallopian tube. A clinicopathologic case report with verification of the diagnosis by immunohistochemical and ultrastructural studies..  157:903-905. 1987

Adenosquamous carcinoma of the fallopian tube: A clinicopathologic case report with verification of the diagnosis by immunohistochemical and ultrastructural studies.  157:903-905. 1987

Amniotic fluid α-fetorotein levels and pregnancy outcome.  157:822-825. 1987

Inhibition of prolactin secretion by antiserum to the α- and β-subunits of gonadotropin.  156:863-868. 1987

The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy.  157:156-160. 1987

Advanced abdominal pregnancy associated with fetal pulmonary hypoplasia: Report of a case.  155:396-397. 1986

Cefotetan versus cefoxitin as prophylaxis in hysterectomy.  154:960-963. 1986

The role of biofeedback in Kegel exercise training for stress urinary incontinence.  154:58-64. 1986

Examination of data base in midforceps delivery study.  153:814. 1985

Decreased levels of amniotic fluid α-fetoprotein associated with Down syndrome.  153:541-544. 1985

Reply.  153:594-595. 1985

Low birth weight, intrauterine growth retardation, and preterm delivery.  152:980-984. 1985

Application of Doppler echocardiography in the assessment of fetal cardiac disease.  151:951-957. 1985

Fatal meconium aspiration syndrome occurring despite airway management considered appropriate.  151:731-736. 1985

Umbilical cord pH, Pco2, and bicarbonate following uncomplicated term vaginal deliveries.  151:798-800. 1985

Neonatal mortality in infants born weighing 501 to 1000 grams. The influence of changes in birth weight distribution and birth weight-specific mortality rates on neonatal survival.  151:608-611. 1985

Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive device.  150:998-999. 1984

Characteristics, mortality, and outcome of higher-birth weight infants who require intensive care.  149:875-879. 1984

Apgar scores and umbilical arterial pH in preterm newborn infants.  149:651-654. 1984

Survival of infants with low birth weight and early gestational age, 1979 to 1981.  149:508-511. 1984

Reply to Campbell et al.  149:241-242. 1984

Adenomatous endocervical hyperplasia resulting in myxometra.  148:827-829. 1984

Second-stage fetal tachycardia and neonatal infection.  148:779-781. 1984

The use of real-time ultrasound as an aid during difficult therapeutic abortion procedures.  148:826-827. 1984

Transient fetal anuria of unknown etiology: A case report.  149:87. 1984

Umbilical cord pH and PCO2: Effect of interval from delivery to determination.  148:191-194. 1984

Cervical choriocarcinoma associated with an intrauterine contraceptive device: A case report.  147:343-344. 1983

Ritodrine hydrochloride infusion in pregnant baboons. II. Sodium and water compartment alterations.  147:254-259. 1983

In caul delivery of the very premature Infant.  145:645-646. 1983

Hemodynamic parameters following pelvic exenteration.  146:882-892. 1983

Ritodrine hydrochloride infusion in pregnant baboons. I. Biophysical effects.  146:916-924. 1983

The effect of 17 α-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.  146:187-190. 1983

The variability of viability: The effect of physicians' perceptions of viability on the survival of very low-birth weight infants.  143:678-684. 1982

Hypofibrinogenemia as a cause of delayed postpartum hemorrhage.  143:230-231. 1982

Fetal heart rate reactivity before and after maternal jogging during the third trimester.  142:545-547. 1982

Urinary diversion in patients undergoing pelvic exenteration.  142:883-889. 1982

Reply to Dr. Semchyshyn.  139:235-237. 1981

Verrucous lesions of the female genitalia. I. Giant condylomata.  137:412-418. 1980

Verrucous lesions of the female genitalia. II. Verrucous carcinoma.  137:419-424. 1980

Acute pulmonary edema associated with molar pregnancies: A high-risk factor for development of persistent trophoblastic disease.  136:412-415. 1980

Appraisal of "rigid" blood glucose control during pregnancy in the overtly diabetic woman.  135:853-862. 1979

Reply to Dr. Kumarasamy.  135:549-550. 1979

Desoxycorticosterone in normal pregnancy. II. Cortisol-dependent fluctuations in free plasma desoxycorticosterone.  133:644-648. 1979

False negative oxytocin challenge test associated with abdominal pregnancy.  133:108-110. 1979

Desoxycorticosterone in normal pregnancy. I. Sequential studies of the secretory patterns of desoxycorticosterone, aldosterone, and cortisol.  132:414-420. 1978

Reply to Dr. Crulkshank.  130:500-501. 1978

The premature breech.  127:240-244. 1977

Outpatient evaluation of patients with atypical Papanicolaou smears: Contribution of endocervical curettage.  126:122-128. 1976

Oral prostaglandin E2 for labor induction in high-risk pregnancy.  125:881-888. 1976

Iatrogenic respiratory distress syndrome. An analysis of obstetric events preceding delivery of infants who develop respiratory distress syndrome.  123:617-620. 1975

The postpartum renal status of women with untreated asymptomatic bacteriuria during pregnancy..  99:221-227. 1967